These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 2476546

  • 1. Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons.
    Barrett JE, Zhang L, Ahlers ST, Wojnicki FH.
    J Pharmacol Exp Ther; 1989 Sep; 250(3):788-94. PubMed ID: 2476546
    [Abstract] [Full Text] [Related]

  • 2. Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding.
    Mansbach RS, Harrod C, Hoffmann SM, Nader MA, Lei Z, Witkin JM, Barrett JE.
    J Pharmacol Exp Ther; 1988 Jul; 246(1):114-20. PubMed ID: 2455786
    [Abstract] [Full Text] [Related]

  • 3. Neurochemical changes correlated with behavior maintained under fixed-interval and fixed-ratio schedules of reinforcement.
    Barrett JE, Hoffmann SM.
    J Exp Anal Behav; 1991 Sep; 56(2):395-405. PubMed ID: 1720163
    [Abstract] [Full Text] [Related]

  • 4. Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
    Gleeson S, Ahlers ST, Mansbach RS, Foust JM, Barrett JE.
    J Pharmacol Exp Ther; 1989 Sep; 250(3):809-17. PubMed ID: 2476547
    [Abstract] [Full Text] [Related]

  • 5. Effects of methaqualone on punished and nonpunished behavior.
    Witkin JM, Katz JL, Barrett JE.
    J Pharmacol Exp Ther; 1981 Jul; 218(1):1-6. PubMed ID: 7241372
    [Abstract] [Full Text] [Related]

  • 6. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
    Goldberg SR, Morse WH, Goldberg DM.
    J Pharmacol Exp Ther; 1981 Mar; 216(3):500-9. PubMed ID: 7205630
    [Abstract] [Full Text] [Related]

  • 7. Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
    De Boer SF, Katz JL, Valentino RJ.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):335-42. PubMed ID: 1625207
    [Abstract] [Full Text] [Related]

  • 8. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E, Sanna PP, Koob GF.
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [Abstract] [Full Text] [Related]

  • 9. Schedule-controlled behavioral effects of the selective 2-amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)propanoic acid antagonist LY293558 in pigeons.
    Benvenga MJ, Ornstein PL, Leander JD.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):164-70. PubMed ID: 7562545
    [Abstract] [Full Text] [Related]

  • 10. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
    Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ.
    J Pharmacol Exp Ther; 2000 Aug; 294(2):588-97. PubMed ID: 10900236
    [Abstract] [Full Text] [Related]

  • 11. Interactions between N-methyl-D-aspartate and CGS 19755 administered intramuscularly and intracerebroventricularly in pigeons.
    France CP, Lu Y, Woods JH.
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1271-7. PubMed ID: 2262905
    [Abstract] [Full Text] [Related]

  • 12. Cerebrospinal fluid concentrations of biogenic amines and corticotropin-releasing factor in adolescent non-human primates as a function of the timing of adverse early rearing.
    Mathew SJ, Coplan JD, Smith EL, Scharf BA, Owens MJ, Nemeroff CB, Mann JJ, Gorman JM, Rosenblum LA.
    Stress; 2002 Sep; 5(3):185-93. PubMed ID: 12186681
    [Abstract] [Full Text] [Related]

  • 13. The effects of levo-alpha-acetylmethadol and its metabolites on schedule-controlled behavior in the pigeon.
    McGivney WT, McMillan DE.
    J Pharmacol Exp Ther; 1981 Feb; 216(2):299-305. PubMed ID: 7463351
    [Abstract] [Full Text] [Related]

  • 14. Interactions of corticotropin-releasing factor with antidepressant and anxiolytic drugs: behavioral studies with pigeons.
    Zhang L, Barrett JE.
    Biol Psychiatry; 1990 May 01; 27(9):953-67. PubMed ID: 1970744
    [Abstract] [Full Text] [Related]

  • 15. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF.
    Psychopharmacology (Berl); 2002 Mar 01; 160(2):113-21. PubMed ID: 11875628
    [Abstract] [Full Text] [Related]

  • 16. Behavioral effects of ovine corticotropin-releasing factor administered to rhesus monkeys.
    Kalin NH.
    Fed Proc; 1985 Jan 01; 44(1 Pt 2):249-53. PubMed ID: 3871411
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of picenadol and its agonist and antagonist isomers on schedule-controlled behavior.
    Leander JD, Zimmerman DM.
    J Pharmacol Exp Ther; 1983 Dec 01; 227(3):671-5. PubMed ID: 6655562
    [Abstract] [Full Text] [Related]

  • 20. Drug effects on multiple and alternating mixed-schedule performance.
    Leander JD.
    J Pharmacol Exp Ther; 1981 Sep 01; 218(3):728-33. PubMed ID: 7264956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.